Equifax Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 95 trades in Equifax Inc (NYSE: EFX) since 2014, across 14 members, worth an estimated $1.1M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 49 buys against 46 sells, a modestly buy-led skew, with Democratic members responsible for 79% of the trades and Republican members 21%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most EFX transactions among those shown, with 15. Other recent filers include Gilbert Cisneros. One notable disclosed move was a purchase by Rohit Khanna on May 15, 2026, up 21.6% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Equifax Inc (EFX) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Equifax congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jul 6, 2026 | Jun 30, 2026 | 6 days | SELL |  $1,001 - $15,000 | +20.90% | Spouse | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | BUY | $1,001 - $15,000 | +21.58% | Spouse | |
Rohit Khanna House | May 11, 2026 | Apr 24, 2026 | 17 days | BUY | $1,001 - $15,000 | +11.64% | Spouse | |
 Gilbert Cisneros House | May 8, 2026 | Apr 14, 2026 | 24 days | SELL | $1,001 - $15,000 | +3.28% | Self | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | SELL | $1,001 - $15,000 | +3.26% | Spouse | |
Gilbert Cisneros House | Apr 7, 2026 | Mar 13, 2026 | 25 days | BUY | $1,001 - $15,000 | +4.49% | Self | |
Rohit Khanna House | Apr 7, 2026 | Mar 10, 2026 | 28 days | BUY | $1,001 - $15,000 | -1.73% | Spouse | |
Rohit Khanna House | Mar 9, 2026 | Feb 24, 2026 | 13 days | SELL | $1,001 - $15,000 | -0.64% | Child | |
Rohit Khanna House | Mar 9, 2026 | Feb 17, 2026 | 20 days | SELL | $1,001 - $15,000 | +0.19% | Spouse | |
Rohit Khanna House | Mar 9, 2026 | Feb 5, 2026 | 32 days | SELL | $1,001 - $15,000 | +1.08% | Spouse |
Equifax (EFX) congressional trading FAQ
Can members of Congress legally trade Equifax (EFX) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Equifax (EFX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Equifax (EFX) trades public?
Yes. Every congressional trade in Equifax (EFX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Equifax (EFX)?
Members of Congress have disclosed 95 trades in Equifax (EFX) worth $1.1M across 14 members, according to public STOCK Act filings.
Which members of Congress have traded Equifax (EFX)?
Recent and active filers of Equifax (EFX) disclosures include Rohit Khanna, Gilbert Cisneros. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Equifax (EFX) more?
Across disclosed Equifax (EFX) trades, 79% were by Democrats and 21% by Republicans, led by Democrats (79%).
What is the most recent congressional Equifax (EFX) trade?
The most recent disclosed Equifax (EFX) trade was a sale by Rohit Khanna, filed Jul 5, 2026.
Browse all stocks Congress tradesCongressional trading overviewEquifax (EFX) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.